Demant completes divestment of cochlear division

After completion of the divestment, the Hearing Implants division is expected to break even in 2024.
Photo: Jens Dresling
Photo: Jens Dresling

Demant has now completed the divestment of its cochlear implant business to Cochlear, the company announced on Tuesday morning. 

”This is in line with expectations and during the transition period we will work closely with Cochlear to ensure a smooth and orderly transition so that Cochlear can continue to serve the existing cochlear implant patients,” Demant writes. 

This is according to plan, as it was previously announced that the divestment was expected to be completed in the second quarter. 

After the completion of the divestment, Hearing Implants is expected to generate a result of 0 in 2024.

English edit: Catherine Brett

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Foto: Mike Blake/Reuters/Ritzau Scanpix

Gilead Sciences CMO to leave early 2025

For subscribers

Further reading